Notice: This company has been marked as potentially delisted and may not be actively trading. PLx Pharma (PLXP) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Analysts Offer Insights on Healthcare Companies: Evaxion Biotech (EVAX) and Protalix (PLX)February 3, 2025 | markets.businessinsider.comGRAVITY Co (NASDAQ:GRVY) Stock Quotes, Forecast and News SummaryOctober 6, 2024 | benzinga.comPLXp/USD - Pullix US DollarAugust 25, 2024 | investing.comProtalix Biotherapeutics Inc (PLX)January 30, 2024 | investing.comVertex Pharmaceuticals Inc VRTXJanuary 22, 2024 | morningstar.comVietnam National Petroleum Group (PLX)October 23, 2023 | investing.comPLx Pharma Inc (PLXPQ)August 21, 2023 | uk.investing.comPLXPQ PLx Pharma Inc.April 21, 2023 | seekingalpha.comPLx Pharma Inc. Enters into a Stalking Horse Asset Purchase Agreement to Sell VAZALORE(R) and Substantially All of its AssetsApril 13, 2023 | marketwatch.comWhy PLx Pharma Shares Are Nosediving TodayApril 12, 2023 | msn.comWhy iMedia Brands Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving PremarketApril 12, 2023 | msn.comWhy PLx Pharma Shares Are Down Over 40% TuesdayApril 11, 2023 | msn.comPLx Pharma Inc. Receives Nasdaq Delisting NoticeApril 11, 2023 | finance.yahoo.comShort Volatility Alert: Plx Pharma IncApril 11, 2023 | msn.comPLx Pharma's Return On Capital Employed InsightsDecember 22, 2022 | msn.comPLx Pharma (PLXP) Q3 2022 Earnings Call TranscriptNovember 11, 2022 | seekingalpha.comPLx Pharma down after Q3 revenue fell 94% Y/YNovember 11, 2022 | seekingalpha.comPLx Pharma Inc. Reports Third Quarter 2022 Results and Provides Business UpdateNovember 10, 2022 | finance.yahoo.comPLx Pharma, Inc. (PLXP) Reports Q3 Loss, Misses Revenue EstimatesNovember 10, 2022 | finance.yahoo.comEarnings Preview: PLx PharmaNovember 10, 2022 | msn.comPLx Pharma Inc. to Report Third Quarter 2022 Financial Results on November 11, 2022, and Provide Business UpdateOctober 26, 2022 | finance.yahoo.comBaseball Legend John Smoltz Featured on PLx Pharma’s Social ChannelsSeptember 12, 2022 | finance.yahoo.comPLx Pharma Inc. (NASDAQ:PLXP) drops to US$21m and insiders who purchased earlier this year lose another US$52kSeptember 5, 2022 | finance.yahoo.comPLXP Aug 2022 5.000 callAugust 20, 2022 | finance.yahoo.comPLx Pharma downgraded at Oppenheimer after Q2 missAugust 15, 2022 | seekingalpha.comPLx Pharma to Explore Strategic Alternatives, Reduces TeamAugust 12, 2022 | marketwatch.comSurvey: Cardiovascular Patients on Aspirin Therapy Prefer VAZALORE® 81 mgAugust 12, 2022 | apnews.comPLx Pharma Q2 Loss Top Estimates, But Revenues Miss; Stock Down 15%August 12, 2022 | markets.businessinsider.comShareholders in PLx Pharma (NASDAQ:PLXP) have lost 88%, as stock drops 13% this past weekAugust 3, 2022 | nasdaq.comPLx Pharma Inc. to Report Second Quarter 2022 Financial Results August 12, 2022, and Provide Business UpdateJuly 27, 2022 | finance.yahoo.comPLx Pharma (NASDAQ:PLXP) shareholders have endured a 89% loss from investing in the stock a year agoJuly 26, 2022 | finance.yahoo.comJMP Securities 2022 Life Sciences ConferenceJune 2, 2022 | benzinga.comPLx Pharma Inc. to Present at JMP Securities 2022 Life Sciences Conference on June 15, 2022June 1, 2022 | finance.yahoo.comPLx Pharma Inc. Showcases VAZALORE at The Annual Meeting of The Society for Cardiovascular Angiography and InterventionsMay 20, 2022 | finance.yahoo.comPLx Pharma, Inc. (PLXP) Reports Q1 Loss, Lags Revenue EstimatesMay 13, 2022 | finance.yahoo.comA Preview Of PLx Pharma's EarningsMay 13, 2022 | benzinga.comWe're Keeping An Eye On PLx Pharma's (NASDAQ:PLXP) Cash Burn RateMay 4, 2022 | finance.yahoo.comPLXP PLx Pharma Inc.May 3, 2022 | seekingalpha.comPLx Pharma Inc. to Discuss 2022 First Quarter Financial Results on May 13, 2022 Conference Call and Provide Business UpdateApril 22, 2022 | finance.yahoo.comThe CFO and Head of Manufacturing & Supply Chain of PLx Pharma Inc. (NASDAQ:PLXP), Rita O'Connor, Just Bought 106% More SharesMarch 21, 2022 | finance.yahoo.comPLx Pharma (NASDAQ:PLXP) Rating Lowered to Sell at Zacks Investment ResearchZacks Investment Research cut PLx Pharma from a "hold" rating to a "sell" rating in a report on Thursday.March 17, 2022 | marketbeat.comLooking Into PLx Pharma's Return On Capital EmployedMarch 16, 2022 | benzinga.comRaymond James Maintains Outperform on PLx Pharma, Lowers Price Target to $12March 14, 2022 | benzinga.comPLx Pharma: Q4 Earnings InsightsMarch 11, 2022 | benzinga.comPLx Pharma Inc. Reports Fourth Quarter and Full Year 2021 Results and Provides Business UpdateMarch 11, 2022 | finance.yahoo.comPLx Pharma's Earnings OutlookMarch 10, 2022 | benzinga.comPLx Pharma Inc. to Present at Oppenheimer & Co’s 32nd Annual Healthcare Conference on March 15, 2022March 1, 2022 | finance.yahoo.comPLx Pharma Inc. to Discuss 2021 Fourth Quarter Financial Results on March 11, 2022 Conference Call and Provide Business UpdateFebruary 22, 2022 | finance.yahoo.comIs PLx Pharma (PLXP) A Worthy Investment?February 21, 2022 | finance.yahoo.comPLx Pharma (NASDAQ:PLXP) investors are sitting on a loss of 32% if they invested a year agoFebruary 17, 2022 | finance.yahoo.com Get PLx Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for PLXP and its competitors with MarketBeat's FREE daily newsletter. Email Address PLXP Media Mentions By Week PLXP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PLXP News Sentiment▼0.000.60▲Average Medical News Sentiment PLXP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PLXP Articles This Week▼00▲PLXP Articles Average Week Get PLx Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for PLXP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NCNA News Today CYCC News Today GRTX News Today INM News Today VCNX News Today PCSA News Today PTIX News Today KTTA News Today APVO News Today RSLS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PLXP) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PLx Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PLx Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.